2023
DOI: 10.2217/fon-2022-0977
|View full text |Cite
|
Sign up to set email alerts
|

Treatment patterns, healthcare resource utilization and costs of HER2-negative gastric/gastroesophageal junction cancer

Abstract: Aim: To describe treatment patterns, healthcare resource utilization and costs in HER2-negative gastric/gastroesophageal (G/GEJ) cancer in the USA. Methods: Retrospective IQVIA Adjudicated Closed Claims database analysis; patients with HER2-negative G/GEJ cancer initiating systemic therapy between October 2016 and December 2019 were identified. Results: Among 1317 patients, platinum plus taxane regimens (54%) were common in neoadjuvant/adjuvant settings. Platinum-taxane (41%) and platinum-fluoropyrimidine (36%… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 20 publications
0
1
0
Order By: Relevance
“…Traditional in-person follow-up strategies in oncology have several limitations, some of which were highlighted by the recent COVID-19 pandemic [ 10 , 11 ]. These strategies demand significant healthcare resources, including time, infrastructure, and expenses, posing a strain on healthcare systems [ 12 , 13 , 14 ]. Geographical barriers can hinder access for patients in remote areas, causing delays in follow-up care.…”
Section: Introductionmentioning
confidence: 99%
“…Traditional in-person follow-up strategies in oncology have several limitations, some of which were highlighted by the recent COVID-19 pandemic [ 10 , 11 ]. These strategies demand significant healthcare resources, including time, infrastructure, and expenses, posing a strain on healthcare systems [ 12 , 13 , 14 ]. Geographical barriers can hinder access for patients in remote areas, causing delays in follow-up care.…”
Section: Introductionmentioning
confidence: 99%